Compare FMC Corp (FMC) vs Toronto-Dominion Bank (TD) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

TD trades at $123.51, up 0.51% today, with a bullish technical signal from moving averages and a consensus analyst price target of $153.00. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 EPS of $1.74 surpassing the $1.63 estimate. Revenue grew to $61.28 billion in 2025, and the company maintains a strong net income margin of 23.38%. A dividend of $1.12 per share is scheduled for payment on July 31, 2026.

The outlook for TD is positive, supported by earnings momentum and analyst confidence, though risks include volatile cash flows from operations and rising debt levels. The stock's current valuation at a P/E of 20.8 appears reasonable relative to growth, positioning it as a candidate for long-term dividend growth despite near-term overbought technical conditions.